• Sunday, Dec 05, 2021
  • Last Update : 12:36 am

Study: Pfizer, Moderna vaccines less effective against Covid-19 S African variant

  • Published at 01:02 pm March 14th, 2021
Pfizer vaccine Covid
File photo: Vials labelled 'Covid-19 Coronavirus Vaccine' and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021 Reuters

A silver lining could be that both of the vaccines held up well against the UK Covid-19 variant

Although vaccines for Covid-19 has increased in global circulation, a new study now suggests that vaccines produced by Pfizer and Moderna may not prove to be much effective against the South African variant, scientifically dubbed B.1.351.

The study, which has been approved for publishing in the journal Nature, has also raised concerns that such new mutations of the coronavirus that emerged in late 2020 may disrupt the world’s mission to achieve herd immunity through available vaccines.

Researchers specifically studied B.1.351 variant, where they analyzed whether or not these pathogens are more resistant to immune responses prompted by the available vaccines.

Samples of biological fluids, namely convalescent plasma and vaccine sera, were collected and studied for the volume of Covid-19-neutralizing antibodies contained among volunteers who recovered from a documented Covid-19 infection, the study said.

When analyzing volunteer vaccinee sera — or fluid from individuals who had been fully vaccinated — the results were similarly grim; neutralizing activity was “significantly lower” against B.1.351, regardless of which vaccine patients received, which highlights concern for potential reinfection

Moderna’s vaccine candidate was found to be 12.4 times less effective against the South African variant, and Pfizer’s was found to have a reduced effectiveness by about 10.3 times.

A silver lining could be that both of the vaccines held up well against the UK Covid-19 variant.

“The overall findings are worrisome, particularly in light of recent reports that both Novavax and Johnson & Johnson vaccines showed a substantial drop in efficacy in South Africa,” the authors concluded in the study. 

First originating in its namesake South Africa – B.1.351 – has quickly spread across the globe. 

After being first detected in the US on January 2021, the country’s Centers for Disease Control and Prevention (CDC) reports 81 confirmed cases across 20 separate jurisdictions.

Both the UK and the South African version of COVID-19 see mutation specifically in the spike protein’s binding sites, which constrains how antibodies produced by the human immune system can fight the virus. 

“If the rampant spread of the virus continues and more critical mutations accumulate, then we may be condemned to chasing after the evolving SARS-CoV-2 continually, as we have long done for influenza virus,” the authors warn. 

In response to the mutations and concerns over efficacy of approved vaccines, pharmaceutical companies have issued studies to monitor how the variants are developing.

“Such considerations require that we stop virus transmission as quickly as is feasible, by redoubling our mitigation measures and by expediting vaccine rollout,” they added in the study.

In January, Pfizer announced its vaccine responds well against 16 different mutations. 

Meanwhile, Moderna announced that it was working on developing a booster vaccine to help bridge any gaps its first vaccine misses when fighting a Covid-19 variant.

Facebook 96
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail